Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Aiva Simaite"'
Potential of Electrospun Fibrous Scaffolds for Intestinal, Skin, and Lung Epithelial Tissue Modeling
Autor:
Andreia M. Gonçalves, Filipa Leal, Anabela Moreira, Tobias Schellhorn, Veronika Hefka Blahnová, Scarlett Zeiringer, Karolina Vocetková, Carolin Tetyczka, Aiva Simaite, Matej Buzgo, Eva Roblegg, Pedro F. Costa, Peter Ertl, Eva Filová, Yvonne Kohl
Publikováno v:
Advanced NanoBiomed Research, Vol 3, Iss 4, Pp n/a-n/a (2023)
Herein, intestinal, skin, and pulmonary in vitro tissue models based on electrospun membranes of poly(ε‐caprolactone) (PCL) and cellulose acetate (CA), cellulose acetate phthalate (CAP), ethylcellulose (EC), or methylcellulose (MC) are presented.
Externí odkaz:
https://doaj.org/article/64a58d4b8e81407d954c7d5558132342
Publikováno v:
Polymers, Vol 14, Iss 7, p 1443 (2022)
Nucleic acid vaccines have become a revolutionary technology to give a fast, safe, cost-effective and efficient response against viral infections, such as SARS-CoV-2 or Human papillomavirus (HPV). However, to ensure their effectiveness, the developme
Externí odkaz:
https://doaj.org/article/d74d3dedf39643c482b561d81054b1fa
Autor:
Li Huang, Erico Himawan, Soumaya Belhadj, Raúl Oswaldo Pérez García, François Paquet Durand, Nicolaas Schipper, Matej Buzgo, Aiva Simaite, Valeria Marigo
Publikováno v:
Pharmaceutics, Vol 14, Iss 1, p 74 (2021)
In this study, we developed a novel solid lipid nanoparticle (SLN) formulation for drug delivery of small hydrophilic cargos to the retina. The new formulation, based on a gel core and composite shell, allowed up to two-fold increase in the encapsula
Externí odkaz:
https://doaj.org/article/f4bd2441a579402997fb05d2a0ec51ae
Publikováno v:
Pharmaceutics, Vol 13, Iss 7, p 1072 (2021)
Conventional bivalent IgG antibodies targeting a subgroup of receptors of the TNF superfamily (TNFSF) including fibroblast growth factor-inducible 14 (anti-Fn14) typically display no or only very limited agonistic activity on their own and can only t
Externí odkaz:
https://doaj.org/article/910186da213e42bea0605daf86eb3b2a
Autor:
Li Huang, Erico Himawan, Soumaya Belhadj, Raúl Oswaldo Pérez García, François Paquet Durand, Nicolaas Schipper, Matej Buzgo, Aiva Simaite, Valeria Marigo
Publikováno v:
Pharmaceutics; Volume 14; Issue 1; Pages: 74
Pharmaceutics
Pharmaceutics, Vol 14, Iss 74, p 74 (2022)
Pharmaceutics
Pharmaceutics, Vol 14, Iss 74, p 74 (2022)
In this study, we developed a novel solid lipid nanoparticle (SLN) formulation for drug delivery of small hydrophilic cargos to the retina. The new formulation, based on a gel core and composite shell, allowed up to two-fold increase in the encapsula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76fb6195fabe8290ea34db1f51dd591c
https://hdl.handle.net/11380/1257654
https://hdl.handle.net/11380/1257654
Publikováno v:
Pharmaceutics, Vol 13, Iss 1072, p 1072 (2021)
Pharmaceutics
Volume 13
Issue 7
Pharmaceutics
Volume 13
Issue 7
Conventional bivalent IgG antibodies targeting a subgroup of receptors of the TNF superfamily (TNFSF) including fibroblast growth factor-inducible 14 (anti-Fn14) typically display no or only very limited agonistic activity on their own and can only t
Publikováno v:
Aerotecnica Missili & Spazio. 98:187-197
This paper presents a way to characterize the strength of bioinspired gecko-adhesives. These are the most promising mechanisms, so far, which enable controlled adhesion (i.e. turning it on and off). They emulate the forces present in geckos’ finger
Publikováno v:
ACS Applied Materials & Interfaces. 11:8654-8666
The development of microstructure (gecko-like) adhesives has focused almost solely on their adhesive strength. However, for practical applications, especially in real-world environments, the adhesive's long-term performance is arguably equally import
Autor:
Aakriti Aggarwal, P.R. Anil Kumar, Matej Buzgo, Ellen Byrne, Andrew J. Carr, Chih-Yao Chui, Duncan Q.M. Craig, Zhanfeng Cui, Vinod Damodaran, Pooya Davoodi, Poornima Dubey, Rose Ann G. Franco, Deepa Garg, Elisabeth L. Gill, P. Gopinath, Naresh Kasoju, Hae Won Kim, Remya Komeri, Alok Kumar, Antonina A. Lach, Joana A. Martins, Ishita Matai, Deepthy Menon, Manju Misra, Jimna Mohamed Ameer, Hayley L. Morris, Pierre–Alexis Mouthuy, Shantikumar V. Nair, Chikim Nguyen, Linh Nguyen, Andrew R. Padalhin, Roopesh Pai, Geoff J.M. Parker, Kapil D. Patel, Seeram Ramakrishna, C.R. Reshmi, Mahesh Kumar Sah, Yan Yan Shery Huang, Aiva Simaite, Vinita Takiar, Shreya Thakkar, Fiona Verisqa, Wenyu Wang, Gang Wei, Gareth R. Williams, Fang Yang, Hua Ye, Deng-Guang Yu, Fenglei Zhou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cfd6511d44b78dbe007a2cabc89809b
https://doi.org/10.1016/b978-0-12-822476-2.01002-5
https://doi.org/10.1016/b978-0-12-822476-2.01002-5
Publikováno v:
The 1st International Electronic Conference on Pharmaceutics.
Immunotherapy is considered as a new pillar of cancer treatment. However, the application of some promising immunotherapeutic antibodies, such as antibodies against certain immune-stimulatory receptors of the TNF receptor superfamily (TNFRs), includi